Drug Research
Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance
Samsung Biologics announced a new agreement with Bristol Myers Squibb for large-scale manufacturing of a Bristol Myers Squibb commercial antibody cancer drug substance.
Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug...
News
Pistoia Alliance Enables Instant, Secure Transfer of Analytical Methods and Results Data Ahead of FDA Guidance
The Pistoia Alliance has announced an industry first for its Methods Hub project; the cloud-based collaborative tool now enables the instant transfer and overlaying of analytical methods and results data in a single platform and between different instrument hardware...
News
ST Pharm breaks ground on 2nd oligonucleotide manufacturing plant
ST Pharm said it has taken its first step towards becoming the global leader in the oligonucleotide contract development and manufacturing organization (CDMO) domain with the groundbreaking ceremony for its second oligonucleotide facility.
The new plant will be located in...
Drug Research
As Lonza CEO departs, Catalent scoops up rival CDMO’s bioscience business head to lead biologics
Mere hours after it surfaced that Lonza’s CEO, Pierre-Alain Ruffieux, will step down, the Swiss CDMO has lost another major executive. And this time, the exec is jumping ship to U.S. contract manufacturing rival Catalent.
Monday, Catalent named Lonza’s David...
Drug Research
Drug Diversion Detection Through AI Effective In Hospitals
Research conducted by Wolters Kluwer, an information and software company, suggests that artificial intelligence (AI) can potentially reduce drug diversion in hospitals. The study revealed that over half of managers who implemented AI-based diversion detection programs reported increased confidence...
News
Rentschler Biopharma’s ATMP Facility in UK Receives MHRA Approval
Rentschler Biopharma SE, a leading global contract development and manufacturing organisation (CDMO) forbiopharmaceuticals, including advanced therapy medicinal products (ATMPs), has received the cGMP Manufacturing Compliance Certificate, following the successful inspection by the UK Medicines & Healthcare Products Regulatory Agency...
Drug Research
CordenPharma Inaugurates Increased Peptide Production of the Largest Worldwide SPPS Manufacturing Plant to Meet Growing Market Demand
Following the signature of a multi-year large scale peptide manufacturing agreement earlier this year, CordenPharma is pleased to announce the inauguration of increased commercial peptide production capacity with newly-upgraded facilities at CordenPharma Colorado, the largest Solid-Phase Peptide Synthesis (SPPS) Manufacturing facility worldwide.
After kicking off capital investments in early 2023, CordenPharma successfully completed a series of upgrades and modernizations to the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read